London-based orthopedic device developer Smith & Nephew saw a modest attributable profit increase of 1 percent in the fourth quarter of 2012, from $140 million in 2011 to $142 million in 2012. However, fourth quarter revenue dropped by nearly 3 percent from approximately $1.12 billion in 2011 to $1.1 billion in 2012. Year end attributable profit rose nearly 25 percent from $582 million to $729 million.
Smith & Nephew's revenue for surgical devices decreased by nearly 5 percent in the fourth quarter, with $797 million in 2012 compared to $835 million in 2011. Overall 2012 revenue for surgical devices also dropped 4 percent. Fourth quarter advanced wound management revenue increased by 3 percent, from $271 million to $280.
More Articles on Devices:
Stanmore Receives FDA Approval for Robotic Partial Knee Surgery
Zimmer Must Pay Stryker $70M for Patent Infringement
Victrex Looks for Market Growth in 2013
Smith & Nephew's revenue for surgical devices decreased by nearly 5 percent in the fourth quarter, with $797 million in 2012 compared to $835 million in 2011. Overall 2012 revenue for surgical devices also dropped 4 percent. Fourth quarter advanced wound management revenue increased by 3 percent, from $271 million to $280.
More Articles on Devices:
Stanmore Receives FDA Approval for Robotic Partial Knee Surgery
Zimmer Must Pay Stryker $70M for Patent Infringement
Victrex Looks for Market Growth in 2013